美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA217640"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
51991-990-28 51991-990 HUMAN PRESCRIPTION DRUG Everolimus Everolimus TABLET, FOR SUSPENSION ORAL 20250128 N/A ANDA ANDA217640 Breckenridge Pharmaceutical, Inc. EVEROLIMUS 2 mg/1 4 BLISTER PACK in 1 CARTON (51991-990-28) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (51991-990-99)
51991-990-77 51991-990 HUMAN PRESCRIPTION DRUG Everolimus Everolimus TABLET, FOR SUSPENSION ORAL 20250731 N/A ANDA ANDA217640 Breckenridge Pharmaceutical, Inc. EVEROLIMUS 2 mg/1 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-990-77)
51991-991-28 51991-991 HUMAN PRESCRIPTION DRUG Everolimus Everolimus TABLET, FOR SUSPENSION ORAL 20250128 N/A ANDA ANDA217640 Breckenridge Pharmaceutical, Inc. EVEROLIMUS 3 mg/1 4 BLISTER PACK in 1 CARTON (51991-991-28) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (51991-991-99)
51991-991-77 51991-991 HUMAN PRESCRIPTION DRUG Everolimus Everolimus TABLET, FOR SUSPENSION ORAL 20250731 N/A ANDA ANDA217640 Breckenridge Pharmaceutical, Inc. EVEROLIMUS 3 mg/1 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-991-77)
51991-992-28 51991-992 HUMAN PRESCRIPTION DRUG Everolimus Everolimus TABLET, FOR SUSPENSION ORAL 20250128 N/A ANDA ANDA217640 Breckenridge Pharmaceutical, Inc. EVEROLIMUS 5 mg/1 4 BLISTER PACK in 1 CARTON (51991-992-28) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (51991-992-99)
51991-992-77 51991-992 HUMAN PRESCRIPTION DRUG Everolimus Everolimus TABLET, FOR SUSPENSION ORAL 20250731 N/A ANDA ANDA217640 Breckenridge Pharmaceutical, Inc. EVEROLIMUS 5 mg/1 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-992-77)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase